Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date: June 15, 2017
Purpose: Disclosure of presentation materials under Regulation FD (Item 7.01) intended for use at the Marcum Microcap Conference and other investor communications.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to furnish presentation materials and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses the availability of new presentation materials for investor relations purposes.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use the furnished presentation materials to discuss its business with investors, lenders, and other stakeholders.
- Forward-Looking Statements: The materials speak as of June 15, 2017. The Company explicitly disclaims any obligation to update the materials to reflect future events or circumstances.
- Legal Status: The information is "furnished" and not "filed" under Section 18 of the Securities Exchange Act of 1934, limiting liability and preventing automatic incorporation by reference into other filings.
Key Facts for Investor Verification
- Verify the content of the presentation materials attached as Exhibit 99.1, which are available on the Company's website for 90 days.
- Confirm that the presentation materials are not considered "filed" for liability purposes under Section 18 of the Exchange Act.
- Review subsequent SEC filings (e.g., 10-K, 10-Q) for actual financial performance data, as this 8-K contains no financial metrics.